Ledger.Open graph →
SEC Form D · filed October 19, 2017

Entera Bio Ltd

Offering
$7.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
JERUSALEM, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Roger M. Garceau · Jerusalem, L3DirectorZeev M. Bronfeld · Jerusalem, L3DirectorYonatan M. Malca · Jerusalem, L3DirectorGerald Lieberman · Jerusalem, L3DirectorPhillip Schwartz · Jerusalem, L3Exec · DirectorChaim M. Davis · Jerusalem, L3DirectorLuke M. Beshar · Jerusalem, L3DirectorDavid M. Ben Ami · Jerusalem, L3DirectorGerald Lieberman · Jerusalem, L3DirectorPhillip Schwartz · Jerusalem, L3Exec · DirectorRoger M. Garceau · Jerusalem, L3DirectorChaim M. Davis · Jerusalem, L3DirectorLuke M. Beshar · Jerusalem, L3DirectorZeev M. Bronfeld · Jerusalem, L3DirectorYonatan M. Malca · Jerusalem, L3DirectorDavid M. Ben Ami · Jerusalem, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗